Litigation Details for BAUSCH HEALTH US, LLC v. ALKEM LABORATORIES LTD. (D.N.J. 2020)
✉ Email this page to a colleague
BAUSCH HEALTH US, LLC v. ALKEM LABORATORIES LTD. (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-03-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-04-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 10,105,444; 10,342,875; 10,478,601; 10,512,640; 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH US, LLC v. ALKEM LABORATORIES LTD.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH US, LLC v. ALKEM LABORATORIES LTD. (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2020-03-12 | 1 | Complaint | 394 patent”), 9,861,698 (“the ’698 patent”), 9,877,955 (“the ’955 patent”), and 10,105,444 (“the ’444 …United States Patent Nos. 10,512,640 (“the ’640 patent”); 10,342,875 (“the ’875 patent”); and 10,478,…of United States Patent Nos. 7,214,506 (“the ’506 patent”), 8,039,494 (“the ’494 patent”), 8,486,978 (“…(“the ’978 patent”), 9,302,009 (“the ’009 patent”), 9,566,272 (“the ’272 patent”), 9,662,394 (“the ’394… the expiration of the ’640 patent, the ’875 patent, and the ’601 patent, or such later date as the Court | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
